Share on StockTwits

Henry Schein (NASDAQ:HSIC)‘s stock had its “neutral” rating reaffirmed by investment analysts at Credit Suisse in a note issued to investors on Tuesday. They currently have a $121.00 price target on the stock, up from their previous price target of $120.00. Credit Suisse’s price target would indicate a potential upside of 3.63% from the company’s current price.

Shares of Henry Schein (NASDAQ:HSIC) traded down 0.90% on Tuesday, hitting $115.71. The stock had a trading volume of 324,683 shares. Henry Schein has a 52-week low of $100.64 and a 52-week high of $120.99. The stock has a 50-day moving average of $118.7 and a 200-day moving average of $117.0. The company has a market cap of $9.877 billion and a P/E ratio of 22.97.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Monday, August 4th. The company reported $1.35 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.33 by $0.02. The company had revenue of $2.60 billion for the quarter, compared to the consensus estimate of $2.56 billion. During the same quarter last year, the company posted $1.23 earnings per share. Henry Schein’s revenue was up 9.3% compared to the same quarter last year. On average, analysts predict that Henry Schein will post $5.38 earnings per share for the current fiscal year.

HSIC has been the subject of a number of other recent research reports. Analysts at Leerink Swann raised their price target on shares of Henry Schein from $120.00 to $127.00 in a research note on Tuesday. Separately, analysts at ISI Group cut their price target on shares of Henry Schein from $130.00 to $127.00 in a research note on Monday. They now have a “neutral” rating on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Henry Schein in a research note on Wednesday, June 11th. They now have a $126.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $118.17.

Henry Schein, Inc is a provider of health care products and services to office-based practitioners. It conducts its business through two segments: healthcare distribution and technology.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.